International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

References

Page 1

	Year	Citations
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Massimo Dominici, Katarina Le Blanc, Ingo Mueller, Cytotherapy Regenerative MedicineCell TherapyMinimal CriteriaInternational SocietyMedicine	2006	17.4K
CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance Adam Greenbaum, Yen‐Michael S. Hsu, Ryan B. Day, Nature Regenerative MedicineDevelopmental BiologyMedicineStem Cell ResearchEarly Mesenchymal Progenitors	2013	1.3K
Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury Luis A. Ortiz, Maria Dutreil, Cheryl L. Fattman, Proceedings of the National Academy of Sciences	2007	1K
Human MSC Suppression Correlates With Cytokine Induction of Indoleamine 2,3-Dioxygenase and Bystander M2 Macrophage Differentiation Moïra François, Raphaëlle Romieu‐Mourez, Mengyang Li, Molecular Therapy	2011	700
Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression Guangwen Ren, Xin Zhao, Liying Zhang, The Journal of Immunology Antiadhesion TherapiesCell AdhesionInflammation SiteImmunologyAdult Stem Cell	2010	631
MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines Christian Ries, Virginia Egea, Marisa Karow, Blood	2006	531
MSC-Based Product Characterization for Clinical Trials: An FDA Perspective Michael Mendicino, Alexander M. Bailey, Keith Wonnacott, Cell stem cell Health SciencesMedicineClinical EndpointClinical TrialsBiomarker Discovery	2014	475
Immunological characterization of multipotent mesenchymal stromal cells—The International Society for Cellular Therapy (ISCT) working proposal Mauro Krampera, Jacques Galipeau, Yufang Shi, Cytotherapy Regenerative MedicineCells—the International SocietyCell TherapyMedicineImmunology	2013	458
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease Partow Kebriaei, Luis Isola, Erkut Bahceci, Biology of Blood and Marrow Transplantation	2009	431
Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models Lianhua Bai, Donald P. Lennon, Arnold I. Caplan, Nature Neuroscience Regenerative MedicineMultiple Sclerosis ModelsCell TherapyHepatocyte Growth FactorMedicine	2012	421

Page 1